Acurx Pharmaceuticals, Inc.
ACXP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001736243
No open-market purchases or sales by Acurx Pharmaceuticals, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $185.5K in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Acurx Pharmaceuticals, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 23 | 26 | +3 |
| Shares | 1.09M | 1.25M | +156.2K (+14.3%) |
| Value | $4.18M | $3.05M | −$1.13M (−27.0%) |
New holders (8)
Institutions that held Acurx Pharmaceuticals, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| NBC Securities, Inc. | 14,000 | $34.0K | 0.00% |
| Group One Trading, L.P. | 13,481 | $33.0K | 0.00% |
| XTX Topco Ltd | 13,041 | $31.9K | 0.00% |
| Two Sigma Investments, LP | 12,986 | $31.8K | 0.00% |
| Simplex Trading, LLC | 10,729 | $26.0K | 0.00% |
| Patriot Financial Group Insurance Agency, LLC | 10,385 | $25.4K | 0.00% |
| Cambridge Investment Research Advisors, Inc. | 10,000 | $25.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 2,868 | $7.03K | 0.00% |
Sold out (5)
Institutions that held Acurx Pharmaceuticals, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Citadel Advisors LLC | 13,697 | $52.5K |
| Sigma Planning Corp | 10,000 | $38.3K |
| Advisory Services Network, LLC | 1,182 | $4.53K |
| JPMorgan Chase & Co | 511 | $1.96K |
| Bank of America Corp | 14 | $54 |